Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Netskope Appoints Government Veteran Joseph Welsh to Lead U.S. Public Sector Sales
-
Cloudcure Launches Companion App to Close Clinical Adherence Gap in Metabolic Health
-
Coherent Launches 700mW Uncooled Micro-Pump Lasers for Improving Efficiency of Scale-Across Networks
-
Asurint Names Vince Pascarella as New General Counsel
-
Change in the amount of Luotea Plc’s own shares
-
Municipality Finance will redeem early notes issued under its MTN programme
-
ASML reports transactions under its current share buyback program
-
InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results
-
Mega raises $11.5M to give every SMB an enterprise-grade growth team, without the agency
-
Alectra employees step up for Coldest Night of the Year, raising $15,000 to support local communities
-
GOWIN Semiconductor Announces New FPGA Families for 2026
-
KommuneKredit announces Annual Report 2025
-
Actuate Therapeutics Launches Strategic Research Initiative to Combine Elraglusib with RAS Inhibitors
-
Mink Ventures Completes Drilling at Montcalm Ni Cu Co Project
-
Poster Presentation Demonstrating Combination Benefit of Narmafotinib in Preclinical Kras-Mutated Cancer Models
-
DIRECTOR / PDMR NOTIFICATION
-
Genius Group announces 2025 Financial Results with 80% Pro Forma Revenue Growth to $13.6 Million
-
Viridien: Information on the total number of voting rights and shares
-
ISSUE OF EQUITY AND TOTAL VOTING RIGHTS
-
IP Strategy to Participate at the Canaccord Genuity 6th Annual Digital Assets Virtual Symposium
-
SeaStar Medical to Present at the Life Sciences Investor Forum on March 11th
-
NOAA Determines TMC USA’s Consolidated Deep-Seabed Mining Application is in Substantial Compliance
-
Biodexa Announces Support for Life’s a Polyp Foundation First U.S. Patient Advocacy Group for FAP Patients
-
Aurora Mobile's EngageLab Launches OpenClaw Skills, Empowering AI Agents to Connect with the Real World
-
Pelthos Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026
-
Capricor Therapeutics to Present Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Update on March 12
-
Hudson Technologies to Attend 38th Annual Roth Conference
-
Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
-
Tenaya Therapeutics Presents Preclinical Data at MDA 2026 Highlighting TN-301’s Potential to Correct Skeletal and Cardiac Muscle Decline in Duchenne Muscular Dystrophy
-
Kawasaki Motors Manufacturing Corp. Wins Showcase Award for EVO Series Engines at Coolest Things Made in Missouri Event
-
Scrum Alliance® Announces Partnership With The Pathwayz Group
-
Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Approval of Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) ▼
-
Aurora Mobile's EngageLab Launches OpenClaw Skills, Empowering AI Agents to Connect with the Real World
-
JFB (NASDAQ: JFB) Announces XTEND Delivery of Tactical Drone Systems Under Defense Contract Valued at Up to $25 Million
-
NovelMed Therapeutics Announces Regulatory Clearance for Subcutaneous Ruxoprubart and Reports Positive Phase II Intravenous Monotherapy Results in PNH
-
UPDATE – Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses
-
Jet.AI Inc. Reports Full Year 2025 Financial Results
-
Founder Group Limited Secures US$4 million 25.4MW Utility-Scale Solar Contract under Malaysia’s CGPP Programme
-
Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24
-
Powell Max Limited Successfully Repositions for Its Next Phase of Growth
-
Prairie Operating Co. Announces Participation in Upcoming Conference
-
OZOP Energy Solutions, Inc. Highlights NBA Athlete Partnership Through Varon USA’s Joint Venture in Ballislife Drink
-
GlobalFoundries Announces Availability of AutoPro150 eMRAM Technology on Enhanced FDX Platform for Advanced Automotive Applications
-
First-ever Dental Dedicated MRI Validated in Clinical Trial and Cleared by FDA for Advanced Soft-Tissue Diagnostics
-
SRx Health Solutions Launches EventHorizonIQ Subscription for Individual and Institutional Traders
-
Alico to Participate at 38th Annual Roth Conference
-
Eagle Nuclear Energy Corp. to Ring Nasdaq Opening Bell on March 11
-
Biodexa Announces Support for Life’s a Polyp Foundation First U.S. Patient Advocacy Group for FAP Patients
-
Nasus Pharma to Present Topline Analysis from NS002 Intranasal Epinephrine Powder Phase 2 Single and Repeat Dose Clinical Study
-
SS Innovations Announces Completion of an $18.6 Million Private Placement to Support Growth Initiatives
